Profit Or Loss [Abstract]

BerGenBio - Filing #2581090

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
389,000 NOK
774,000 NOK
Profit (loss) from operating activities
305,635,000 NOK
314,464,000 NOK
Finance income
15,027,000 NOK
15,993,000 NOK
Finance costs
11,514,000 NOK
10,894,000 NOK
Profit (loss) before tax
302,122,000 NOK
309,364,000 NOK
Tax expense (income)
0 NOK
0 NOK
Profit (loss)
302,122,000 NOK
302,122,000 NOK
309,364,000 NOK
309,364,000 NOK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
3.41
3.52

Talk to a Data Expert

Have a question? We'll get back to you promptly.